TD Asset Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

TD Asset Management’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,500	Closed	-$53K	–	1508
2022 Q3	$53K	Sell	26,500 -15,105	-36%	-$45K	﹤0.01%	1438
2022 Q2	$128K	Sell	41,605 -36,900	-47%	-$225K	﹤0.01%	1406
2022 Q1	$567K	Sell	78,505 -3,993	-5%	-$39.3K	﹤0.01%	1330
2021 Q4	$1.35M	Buy	82,498 +38,100	+86%	+$443K	﹤0.01%	1228
2021 Q3	$442K	Hold	44,398	–	–	﹤0.01%	1410
2021 Q2	$439K	Hold	44,398	–	–	﹤0.01%	1405
2021 Q1	$442K	Buy	+44,398	New	+$459K	﹤0.01%	1416

Other funds holding PRDS

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

TD Asset Management's PRDS Position: Q4 2022 in Review

TD Asset Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q4 2022, closing a stake of 26,500 shares — an estimated $53K sold.

TD Asset Management first reported a position in PRDS in Q1 2021 and held it in 7 quarters. The position peaked at $1.35M in Q4 2021. 65 funds tracked by Wall St. Rank hold PRDS as of Q4 2022.

TD Asset Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
TD Asset Management sold 26,500 Pardes Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $53K.
TD Asset Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
TD Asset Management's Pardes Biosciences, Inc. Common Stock position peaked at $1.35M in Q4 2021.
65 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q4 2022.

Based on TD Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.